Home › Funds › Scopia Capital Management › INDV
Scopia Capital Management position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Latest position (Q2 2025)1.65M sh
Reported value held$24.39M
Portfolio Weight2.98%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.31M | $191.74M | New |
| Q4 2023 | 8.26M | $126.15M | Reduce |
| Q1 2024 | 6.03M | $129.06M | Reduce |
| Q2 2024 | 5.90M | $92.50M | Reduce |
| Q3 2024 | 1.28M | $12.52M | Reduce |
| Q4 2024 | 1.48M | $18.44M | Add |
| Q1 2025 | 1.88M | $17.93M | Add |
| Q2 2025 | 1.65M | $24.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INDV
- BlackRock Inc 18.71M sh · $767.65M · Q2 2026
- Vanguard Group 5.47M sh · $196.40M · Q4 2025
- Morgan Stanley 3.40M sh · $139.33M · Q2 2026
- Franklin Resources 3.32M sh · $136.07M · Q2 2026
- Geode Capital Management 3.16M sh · $129.68M · Q2 2026
- Citadel Advisors 2.87M sh · $117.72M · Q2 2026
- Millennium Management 2.10M sh · $86.12M · Q2 2026
- Invesco Ltd 1.84M sh · $75.62M · Q2 2026
- UBS Group AG 1.68M sh · $68.96M · Q2 2026
- Arrowstreet Capital 1.64M sh · $67.37M · Q2 2026
- Point72 Asset Management 1.25M sh · $51.31M · Q2 2026
- Northern Trust Corp 1.24M sh · $50.95M · Q2 2026